HIV and AIDS Trial, Recruiting NCT06586619 Sponsor: Florida International University Condition: HIV and AIDS
Back to Hiv Aids

HIV and AIDS Trial, Recruiting

NCT06586619
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are between 50 and 75 years old
  • People who have been diagnosed with HIV by a healthcare professional, with confirmation provided at the start of the study (via a photo of a recent lab report or medication bottle showing their name)
  • People who have mild to moderate depression symptoms, based on a specific depression questionnaire called the PHQ-9 (a score higher than 5 but lower than 19)
  • People who are able to give informed consent, as assessed using a cognitive screening tool called the GAIN Cognitive Impairment Scale
  • People who have signed and dated a consent form agreeing to take part
  • People who have reliable internet access and own a smartphone
  • People who have not regularly practised mind-body activities (such as yoga or meditation) on a weekly basis for more than 3 months in the past year
  • People who are willing to take part for the full 12-week program and follow-up check-ins over a total of 12 months
  • People who have had stable housing for the past 60 days and expect to have stable housing for the next 60 days
  • People who speak and understand English

Who may not be able to join:

  • People who are identified as being at high risk for suicide based on a screening tool called the CCSR
  • People who have taken part in a mental health study within the last 12 months
  • People who are currently exercising at least 150 minutes per week

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Gladys E Ibanez, Ph.D., Florida International University

Phone: 305-348-4920

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Florida International University
Registry
ClinicalTrials.gov
Start date
4 August 2025
Est. completion
1 May 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Depressive Symptoms

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov